FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

George Thalmann

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Living Beings

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
George N Thalmann
To transfuse or not to transfuse: is it really a question?
Beat Roth; Frédéric D Birkhäuser; Fiona C Burkhard; Mirjam Huwyler; George N Thalmann; Pascal Zehnder; Urs E Studer
Parenteral nutrition does not improve postoperative recovery from radical cystectomy: results of a prospective randomised trial.
Felix Moltzahn; Beat Roth; George N Thalmann; Frédéric D Birkhäuser; Katharina Haeni; Pascal Zehnder
Peri-interventional antibiotic prophylaxis only vs continuous low-dose antibiotic treatment in patients with JJ stents: a prospective randomised trial analysing the effect on urinary tract infections and stent-related symptoms.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of George Thalmann (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: George N Thalmann
To transfuse or not to transfuse: is it really a question?
European urology 2013;63(5):846-7.
2013: Beat Roth; Frédéric D Birkhäuser; Fiona C Burkhard; Mirjam Huwyler; George N Thalmann; Pascal Zehnder; Urs E Studer
Parenteral nutrition does not improve postoperative recovery from radical cystectomy: results of a prospective randomised trial.
European urology 2013;63(3):475-82.
2013: Felix Moltzahn; Beat Roth; George N Thalmann; Frédéric D Birkhäuser; Katharina Haeni; Pascal Zehnder
Peri-interventional antibiotic prophylaxis only vs continuous low-dose antibiotic treatment in patients with JJ stents: a prospective randomised trial analysing the effect on urinary tract infections and stent-related symptoms.
BJU international 2013;111(2):289-95.
2012: Livio Mordasini; Christian Rummel; George N Thalmann; Rajeev K Verma; Christian Weisstanner; Roland Wiest; Thomas M Kessler
Chronic pelvic pain syndrome in men is associated with reduction of relative gray matter volume in the anterior cingulate cortex compared to healthy controls.
The Journal of urology 2012;188(6):2233-7.
2012: Frédéric D Birkhäuser; Urs Eichenberger; Robert Greif; Cédric Luyet; Marius Wipfli; George N Thalmann
Vasectomy reversal with ultrasonography-guided spermatic cord block.
BJU international 2012;110(11):1796-800.
2012: Pirus Ghadjar; George N Thalmann
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group.
BJU international 2012;110(10):E431-2; author reply E432.
2012: Frédéric D Birkhäuser; Marco G Cecchini; Louis de Meuron; Beat Roth; Celine Schumacher; Roland Seiler; George N Thalmann; Antoinette Wetterwald; Pascal Zehnder; Urs E Studer
Occlusion of seminal vesicles increases sexual activity in a mouse model.
European urology 2012;62(5):855-62.
2012: Christian Ruiz; Hugo Stocker; Susanna Stürm; Luigi M Terracciano; George N Thalmann; Stephen Wyler; Tobias Zellweger; Mariacarla Andreozzi; Alexander Bachmann; Lukas Bubendorf; Marco G Cecchini; Thomas C Gasser; Edward P Gelmann; Markus Germann; Andrew G Glass; Silvia Gluderer; Heikki J Helin; Pasi A Koivisto; Martin Oeggerli; Cyrill Rentsch
High NRBP1 expression in prostate cancer is linked with poor clinical outcomes and increased cancer cell growth.
The Prostate 2012;72(15):1678-87.
2012: Markus Germann; Natalia Guzmán-Ramirez; Marco G Cecchini; Zoran Culig; Gabri van der Pluijm; Antoinette Wetterwald; Elizabeth D Williams; George N Thalmann
Stem-like cells with luminal progenitor phenotype survive castration in human prostate cancer.
Stem cells (Dayton, Ohio) 2012;30(6):1076-86.
2012: Beat Roth; Frédéric D Birkhäuser; Fiona C Burkhard; George N Thalmann; Pascal Zehnder; Urs E Studer
Is bilateral extended pelvic lymphadenectomy necessary for strictly unilateral invasive bladder cancer?
The Journal of urology 2012;187(5):1577-82.
2012: Sara Peeters; Stefan Preisser; Barbara Rothen-Rutishauser; George N Thalmann; Antoinette Wetterwald; Arthur Bailey; Christina Brandenberger; Michael Kitz; Martin Frenz
Mechanisms of nanoparticle-mediated photomechanical cell damage.
Biomedical optics express 2012;3(3):435-46.
2012: George N Thalmann
It is time to move on.
European urology 2012;61(3):478-9.
2012: Gianluca Giannarini; Daniel P Nguyen; George N Thalmann; Harriet C Thoeny
Diffusion-weighted magnetic resonance imaging detects local recurrence after radical prostatectomy: initial experience.
European urology 2012;61(3):616-20.
2012: Roland Seiler; George N Thalmann; Michael von Gunten; Achim Fleischmann
High CD10 expression predicts favorable outcome in surgically treated lymph node-positive bladder cancer patients.
Human pathology 2012;43(2):269-75.
2011: Roland Seiler; George N Thalmann; Achim Fleischmann
MMP-2 and MMP-9 in lymph-node-positive bladder cancer.
Journal of clinical pathology 2011;64(12):1078-82.
2011: Gianluca Giannarini; Thomas M Kessler; Frédéric D Birkhäuser; George N Thalmann; Urs E Studer
Antegrade perfusion with bacillus Calmette-Guérin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit?
European urology 2011;60(5):955-60.
2011: Pascal Zehnder; Eila C Skinner; John Stein; Urs E Studer; George N Thalmann; Frédéric Birkhäuser; Fiona C Burkhard; Jie Cai; Sia Daneshmand; Ryan P Dorin; Inderbir S Gill; Gus Miranda; Beat Roth; Donald G Skinner
Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study.
The Journal of urology 2011;186(4):1261-8.
2011: Achim Fleischmann; Diana Rotzer; Roland Seiler; Urs E Studer; George N Thalmann
Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.
European urology 2011;60(2):350-7.
2011: Pirus Ghadjar; Bernhard Isaak; Cyrill Rentsch; George N Thalmann; Frank Behrensmeier; Daniel M Aebersold
Urethral toxicity vs. cancer control--lessons to be learned from high-dose rate brachytherapy combined with intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer.
Brachytherapy 2011;10(4):286-94.
2011: Achim Fleischmann; Carla Rocha; Nikolina Saxer-Sekulic; Inti Zlobec; Guido Sauter; George N Thalmann
High CD10 expression in lymph node metastases from surgically treated prostate cancer independently predicts early death.
Virchows Archiv : an international journal of pathology 2011;458(6):741-8.
2011: Meike Körner; Beatriche Waser; George N Thalmann; Jean Claude Reubii
High expression of NPY receptors in the human testis.
Molecular and cellular endocrinology 2011;337(1-2):62-70.
2011: Achim Fleischmann; Carla Rocha; Nikolina Saxer-Sekulic; Inti Zlobec; Guido Sauter; George N Thalmann
High-level cytoplasmic cyclin D1 expression in lymph node metastases from prostate cancer independently predicts early biochemical failure and death in surgically treated patients.
Histopathology 2011;58(5):781-9.
2011: Pascal Zehnder; Beat Roth; Frédéric Birkhäuser; Silvia Schneider; Rolf Schmutz; George N Thalmann; Urs E Studer
A prospective randomised trial comparing the modified HM3 with the MODULITH® SLX-F2 lithotripter.
European urology 2011;59(4):637-44.
2011: Frédéric D Birkhäuser; Pascal Zehnder; Beat Roth; Leander Schürch; Katharina Ochsner; Rita Willener; George N Thalmann; Fiona C Burkhard; Urs E Studer
Irrigation of continent catheterizable ileal pouches: tap water can replace sterile solutions because it is safe, easy, and economical.
European urology 2011;59(4):518-23.
2011: Achim Fleischmann; Carla Rocha; Sylviane Schobinger; Roland Seiler; Birgitt Wiese; George N Thalmann
Androgen receptors are differentially expressed in Gleason patterns of prostate cancer and down-regulated in matched lymph node metastases.
The Prostate 2011;71(5):453-60.
2011: Roland Seiler; Michael von Gunten; George N Thalmann; Achim Fleischmann
Extracapsular extension but not the tumour burden of lymph node metastases is an independent adverse risk factor in lymph node-positive bladder cancer.
Histopathology 2011;58(4):571-8.
2011: Pirus Ghadjar; Fiona C Burkhard; Oliver Gautschi; George N Thalmann; Urs E Studer
Induction chemotherapy for unresectable urothelial carcinoma of the bladder.
BJU international 2011;107(6):894-7.
2011: Beat Roth; Frédéric D Birkhäuser; Pascal Zehnder; Fiona C Burkhard; George N Thalmann; Urs E Studer
Readaptation of the peritoneum following extended pelvic lymphadenectomy and cystectomy has a significant beneficial impact on early postoperative recovery and complications: results of a prospective randomized trial.
European urology 2011;59(2):204-10.
2011: Spyridon Arampatzis; George N Thalmann; Heinz Zimmermann; Aristomenis K Exadaktylos
Lunar tractive forces and renal stone incidence.
Emergency medicine international 2011;2011():813460.
2011: Chiara Secondini; Antoinette Wetterwald; Ruth Schwaninger; George N Thalmann; Marco G Cecchini
The role of the BMP signaling antagonist noggin in the development of prostate cancer osteolytic bone metastasis.
PloS one 2011;6(1):e16078.
2010: Silvan Boxler; Valentin Djonov; Thomas M Kessler; Ruslan Hlushchuk; Lucas M Bachmann; Ulrike Held; Regula Markwalder; George N Thalmann
Matrix metalloproteinases and angiogenic factors: predictors of survival after radical prostatectomy for clinically organ-confined prostate cancer?
The American journal of pathology 2010;177(5):2216-24.
2010: George N Thalmann; Hong Rhee; Robert A Sikes; Sen Pathak; Ashi Multani; Haiyen E Zhau; Fray F Marshall; Leland W K Chung
Human prostate fibroblasts induce growth and confer castration resistance and metastatic potential in LNCaP Cells.
European urology 2010;58(1):162-71.
2010: Christel van den Hoogen; Geertje van der Horst; Henry Cheung; Jeroen T Buijs; Jenny M Lippitt; Natalia Guzmán-Ramírez; Freddie C Hamdy; Colby L Eaton; George N Thalmann; Marco G Cecchini; Rob C M Pelger; Gabri van der Pluijm
High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer.
Cancer research 2010;70(12):5163-73.
2010: Roland Seiler; Michael von Gunten; George N Thalmann; Achim Fleischmann
Pelvic lymph nodes: distribution and nodal tumour burden of urothelial bladder cancer.
Journal of clinical pathology 2010;63(6):504-7.
2010: Chin Hu Ong; Martin Schmitt; George N Thalmann; Urs E Studer
Individualized seminal vesicle sparing cystoprostatectomy combined with ileal orthotopic bladder substitution achieves good functional results.
The Journal of urology 2010;183(4):1337-41.
2010: Beat Roth; Michael P Wissmeyer; Pascal Zehnder; Frédéric D Birkhäuser; George N Thalmann; Thomas M Krause; Urs E Studer
A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder.
European urology 2010;57(2):205-11.
2009: George N Thalmann
Words of wisdom. Re: Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer.
European urology 2009;56(5):884-5.
2009: Pirus Ghadjar; Nicole Gwerder; Axel Madlung; Frank Behrensmeier; George N Thalmann; Roberto Mini; Daniel M Aebersold
Use of gold markers for setup in image-guided fractionated high-dose-rate brachytherapy as a monotherapy for prostate cancer.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2009;185(11):731-5.
2009: Natalia Guzmán-Ramírez; Maureen Völler; Antoinette Wetterwald; Markus Germann; Neil A Cross; Cyrill Rentsch; Jack Schalken; George N Thalmann; Marco G Cecchini
In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue.
The Prostate 2009;69(15):1683-93.
2009: Pirus Ghadjar; Oscar Matzinger; Bernhard Isaak; Frank Behrensmeier; Andrea Stroux; Cyrill Rentsch; George N Thalmann; Daniel M Aebersold
Association of urethral toxicity with dose exposure in combined high-dose-rate brachytherapy and intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;91(2):237-42.
2009: Cyrill Rentsch; Marco G Cecchini; George N Thalmann
Loss of inhibition over master pathways of bone mass regulation results in osteosclerotic bone metastases in prostate cancer.
Swiss medical weekly 2009;139(15-16):220-5.
2009: Achim Fleischmann; Sylviane Schobinger; Martin Schumacher; George N Thalmann; Urs E Studer
Survival in surgically treated, nodal positive prostate cancer patients is predicted by histopathological characteristics of the primary tumor and its lymph node metastases.
The Prostate 2009;69(4):352-62.
2008: Achim Fleischmann; S Schobinger; Regula Markwalder; Martin C Schumacher; Fiona C Burkhard; George N Thalmann; Urs E Studer
Prognostic factors in lymph node metastases of prostatic cancer patients: the size of the metastases but not extranodal extension independently predicts survival.
Histopathology 2008;53(4):468-75.
2008: Daniel Peternac; Irena Klima; Marco G Cecchini; Ruth Schwaninger; Urs E Studer; George N Thalmann
Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progression.
The Prostate 2008;68(12):1307-18.
2008: Martin C Schumacher; Fiona C Burkhard; George N Thalmann; Achim Fleischmann; Urs E Studer
Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy.
European urology 2008;54(2):344-52.
2008: Thomas M Kessler; Katharina Ochsner; Urs E Studer; George N Thalmann
Diabetes mellitus: does it impair urinary continence after radical cystoprostatectomy and ileal orthotopic bladder substitution?
European urology 2008;53(5):1040-6.
2008: Nivedita Bhatta Dhar; Eric A Klein; Alwyn M Reuther; George N Thalmann; Stephan Madersbacher; Urs E Studer
Outcome after radical cystectomy with limited or extended pelvic lymph node dissection.
The Journal of urology 2008;179(3):873-8; discussion 878.
2008: Dirk H Westermann; Hubert Schefer; George N Thalmann; Evanthia Karamitopoulou-Diamantis; Martin F Fey; Urs E Studer
Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
The Journal of urology 2008;179(1):163-6.
2008: Agostino Mattei; Frank G Fuechsel; Nivedita Bhatta-Dhar; Sebastian H Warncke; George N Thalmann; Thomas Krause; Urs E Studer
The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study.
European urology 2008;53(1):118-25.
2008: George N Thalmann
Organ preservation for T1G3 bladder cancer: is it feasible?
European urology 2008;53(1):27-9.
2007: Jeroen T Buijs; Cyrill Rentsch; Gijsbertus T J van der Horst; Petra G M van Overveld; Antoinette Wetterwald; Ruth Schwaninger; Nico Henriquez; Peter ten Dijke; Fran Borovecki; Regula Markwalder; George N Thalmann; Socrates E Papapoulos; Rob C M Pelger; Slobodan Vukicevic; Marco G Cecchini; Clemens W G M Löwik; Gabri van der Pluijm
BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo.
The American journal of pathology 2007;171(3):1047-57.
2007: George N Thalmann
Words of wisdom. Re: Detection of occult lymph node metastases in locally advanced node-negative prostate cancer.
European urology 2007;52(2):608-9.
2007: Gianluca Giannarini; Martin C Schumacher; George N Thalmann; Alain Bitton; Achim Fleischmann; Urs E Studer
Elective management of transitional cell carcinoma of the distal ureter: can kidney-sparing surgery be advised?
BJU international 2007;100(2):264-8.
2007: Ruth Schwaninger; Cyrill Rentsch; Antoinette Wetterwald; Gijsbertus T J van der Horst; Rutger L van Bezooijen; Gabri van der Pluijm; Clemens W G M Löwik; Karin Ackermann; Walter Pyerin; Freddie C Hamdy; George N Thalmann; Marco G Cecchini
Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases.
The American journal of pathology 2007;170(1):160-75.
2006: Martin C Schumacher; Michael Scholz; Erik S Weise; Achim Fleischmann; George N Thalmann; Urs E Studer
Is there an indication for frozen section examination of the ureteral margins during cystectomy for transitional cell carcinoma of the bladder?
The Journal of urology 2006;176(6 Pt 1):2409-13; discussion 2413.
2006: George N Thalmann
Are bladder cancer patients with pT0 disease following radical cystectomy cured of cancer?
Nature clinical practice. Urology 2006;3(10):530-1.
2006: Martin C Schumacher; Fiona C Burkhard; George N Thalmann; Achim Fleischmann; Urs E Studer
Is pelvic lymph node dissection necessary in patients with a serum PSA<10ng/ml undergoing radical prostatectomy for prostate cancer?
European urology 2006;50(2):272-9.
2006: Daniel Peternac; Irena Klima; Marco G Cecchini; Urs E Studer; George N Thalmann
Prostate specific antigen expression does not necessarily correlate with prostate cancer cell growth.
The Journal of urology 2006;176(1):354-60.
2006: Fiona C Burkhard; Thomas M Kessler; Achim Fleischmann; George N Thalmann; Martin Schumacher; Urs E Studer
Nerve sparing open radical retropubic prostatectomy--does it have an impact on urinary continence?
The Journal of urology 2006;176(1):189-95.
2006: Urs E Studer; Fiona C Burkhard; Martin Schumacher; Thomas M Kessler; Harriet C Thoeny; Achim Fleischmann; George N Thalmann
Twenty years experience with an ileal orthotopic low pressure bladder substitute--lessons to be learned.
The Journal of urology 2006;176(1):161-6.
2006: Cyrill Rentsch; Marco G Cecchini; Ruth Schwaninger; Markus Germann; Regula Markwalder; Manfred Heller; Gabri van der Pluijm; George N Thalmann; Antoinette Wetterwald
Differential expression of TGFbeta-stimulated clone 22 in normal prostate and prostate cancer.
International journal of cancer. Journal international du cancer 2006;118(4):899-906.
2005: Alexandra Prtilo; Fredrick S Leach; Regula Markwalder; Andreas Kappeler; Fiona C Burkhard; Marco G Cecchini; Urs E Studer; George N Thalmann
Tissue microarray analysis of hMSH2 expression predicts outcome in men with prostate cancer.
The Journal of urology 2005;174(5):1814-8; discussion 1818.
2005: Gabri van der Pluijm; Ivo Que; Bianca Sijmons; Jeroen T Buijs; Clemens W G M Löwik; Antoinette Wetterwald; George N Thalmann; Socrates E Papapoulos; Marco G Cecchini
Interference with the microenvironmental support impairs the de novo formation of bone metastases in vivo.
Cancer research 2005;65(17):7682-90.
2005: Achim Fleischmann; George N Thalmann; Regula Markwalder; Urs E Studer
Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(10):2358-65.
2005: Fiona C Burkhard; Martin Schumacher; George N Thalmann; Urs E Studer
Is pelvic lymphadenectomy really necessary in patients with a serum prostate-specific antigen level of <10 ng/ml undergoing radical prostatectomy for prostate cancer?
BJU international 2005;95(3):275-8.
2005: Achim Fleischmann; George N Thalmann; Regula Markwalder; Urs E Studer
Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladder.
The American journal of surgical pathology 2005;29(1):89-95.
2004: Urs E Studer; Dieter Hauri; Silvia Hanselmann; Dominique Chollet; Hans-Jürg Leisinger; Thomas Gasser; Edgar Senn; Felix B Trinkler; Reto M Tscholl; George N Thalmann; Daniel Dietrich
Immediate versus deferred hormonal treatment for patients with prostate cancer who are not suitable for curative local treatment: results of the randomized trial SAKK 08/88.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(20):4109-18.
2004: Stephan Madersbacher; George N Thalmann; Johannes C Fritsch; Urs E Studer
Is eligibility for a chemotherapy protocol a good prognostic factor for invasive bladder cancer after radical cystectomy?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(20):4103-8.
2004: Thomas M Kessler; Fiona C Burkhard; Petros Perimenis; Hansjörg Danuser; George N Thalmann; Werner W Hochreiter; Urs E Studer
Attempted nerve sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution.
The Journal of urology 2004;172(4 Pt 1):1323-7.
2004: Marco Bisoffi; Irena Klima; Ekaterina Gresko; Paul N Durfee; William Hines; Jeffrey K Griffith; Urs E Studer; George N Thalmann
Expression profiles of androgen independent bone metastatic prostate cancer cells indicate up-regulation of the putative serine-threonine kinase GS3955.
The Journal of urology 2004;172(3):1145-50.
2004: Celi Varol; George N Thalmann; Fiona C Burkhard; Urs E Studer
Treatment of urethral recurrence following radical cystectomy and ileal bladder substitution.
The Journal of urology 2004;172(3):937-42.
2004: George N Thalmann; Regula Markwalder; Osama Shahin; Fiona C Burkhard; Werner W Hochreiter; Urs E Studer
Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy?
The Journal of urology 2004;172(1):70-5.
2004: Robert A Sikes; Brian E Nicholson; Kenneth S Koeneman; N Magnus Edlund; Eric A Bissonette; Michael J Bradley; George N Thalmann; Marco G Cecchini; Kenneth J Pienta; Leland W K Chung
Cellular interactions in the tropism of prostate cancer to bone.
International journal of cancer. Journal international du cancer 2004;110(4):497-503.
2003: Geneviève Clément; Marco Bisoffi; Anita N Finger; Antoinette Wetterwald; George N Thalmann; Marco G Cecchini
Peptabodies as tools to test ligands isolated from phage-displayed peptide libraries.
Journal of immunological methods 2003;276(1-2):135-41.
2003: Michael C Schmid; Marco Bisoffi; Antoinette Wetterwald; Elsbeth Gautschi; George N Thalmann; stefania mitola; Federico Bussolino; Marco G Cecchini
Insulin-like growth factor binding protein-3 is overexpressed in endothelial cells of mouse breast tumor vessels.
International journal of cancer. Journal international du cancer 2003;103(5):577-86.
2003: Stephan Madersbacher; Werner W Hochreiter; Fiona C Burkhard; George N Thalmann; Hansjörg Danuser; Regula Markwalder; Urs E Studer
Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(4):690-6.
2003: Osama Shahin; George N Thalmann; Cyrill Rentsch; L Mazzucchelli; Urs E Studer
A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival.
The Journal of urology 2003;169(1):96-100; discussion 100.
2002: Werner W Hochreiter; George N Thalmann; Fiona C Burkhard; Urs E Studer
Holmium laser enucleation of the prostate combined with electrocautery resection: the mushroom technique.
The Journal of urology 2002;168(4 Pt 1):1470-4.
2002: George N Thalmann; Regula Markwalder; Bernhard Walter; Urs E Studer
Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery.
The Journal of urology 2002;168(4 Pt 1):1381-5.
2002: O Adsan; Marco G Cecchini; Marco Bisoffi; Antoinette Wetterwald; Irena Klima; Hansjörg Danuser; Urs E Studer; George N Thalmann
Can the reverse transcriptase-polymerase chain reaction for prostate specific antigen and prostate specific membrane antigen improve staging and predict biochemical recurrence?
BJU international 2002;90(6):579-85.
2002: Anita N Finger; Marco Bisoffi; Antoinette Wetterwald; Elsbeth Gautschi; Ulrike Hohenfeld; Irena Klima; Beda Stadler; Luca Mazzucchelli; George N Thalmann; Marco G Cecchini
Scavenger receptor block as strategy for the identification of bone marrow homing phages by panning in vivo random peptide phage displayed libraries.
Journal of immunological methods 2002;264(1-2):173-86.
2002: George N Thalmann; Agostino Mattei; Cédric Treuthardt; Fiona C Burkhard; Urs E Studer
Transurethral microwave therapy in 200 patients with a minimum followup of 2 years: urodynamic and clinical results.
The Journal of urology 2002;167(6):2496-501.
2002: Antoinette Wetterwald; Gabri van der Pluijm; Ivo Que; Bianca Sijmons; Jeroen T Buijs; Marcel Karperien; Clemens W G M Löwik; Elsbeth Gautschi; George N Thalmann; Marco G Cecchini
Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease.
The American journal of pathology 2002;160(3):1143-53.
2001: J Schmidt; Stephan Madersbacher; Werner W Hochreiter; George N Thalmann; Urs E Studer
Simultaneous replacement of both ureters with small intestine in a woman with cystinuria.
The Journal of urology 2001;166(6):2315-6.
2001: Robert D Mills; William H Turner; Achim Fleischmann; Regula Markwalder; George N Thalmann; Urs E Studer
Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
The Journal of urology 2001;166(1):19-23.
2000: George N Thalmann; A Sermier; Cyrill Rentsch; K Möhrle; Marco G Cecchini; Urs E Studer
Urinary Interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin.
The Journal of urology 2000;164(6):2129-33.
2000: George N Thalmann; Robert A Sikes; T T Wu; A Degeorges; S M Chang; M Ozen; S Pathak; Leland W K Chung
LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis.
The Prostate 2000;44(2):91-103 Jul 1;44(2).
1999: George N Thalmann; Robert A Sikes; R E Devoll; Jeff Kiefer; Regula Markwalder; Irena Klima; C M Farach-Carson; Urs E Studer; Leland W K Chung
Osteopontin: possible role in prostate cancer progression.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(8):2271-7.
1999: George N Thalmann; S F Graber; A Bitton; Fiona C Burkhard; O Gruenig; Urs E Studer
Transurethral thermotherapy for benign prostatic hyperplasia significantly decreases infravesical obstruction: results in 134 patients after 1 year.
The Journal of urology 1999;162(2):387-93.
1998: T T Wu; Robert A Sikes; Q Cui; George N Thalmann; C Kao; C F Murphy; H Yang; Haiyen E Zhau; Gary Balian; Leland W K Chung
Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines.
International journal of cancer. Journal international du cancer 1998;77(6):887-94.
1997: CL Hugonnet; Hansjörg Danuser; George N Thalmann; Urs E Studer
[Long-term urodynamic and clinical follow-up in 70 patients with ileal bladder replacement combined with an antireflux mechanism or an afferent tubular segment].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 1997;7(6):960-6.
1997: A E Mottaz; Regula Markwalder; M F Fey; Irena Klima; V W Merz; George N Thalmann; R K Ball; Urs E Studer
Abnormal p53 expression is rare in clinically localized human prostate cancer: comparison between immunohistochemical and molecular detection of p53 mutations.
The Prostate 1997;31(4):209-15.
1997: Fiona C Burkhard; Regula Markwalder; George N Thalmann; Urs E Studer
Immunohistochemical determination of p53 overexpression. An easy and readily available method to identify progression in superficial bladder cancer?
Urological research 1997;25 Suppl 1():S31-5.
1996: Urs E Studer; Hansjörg Danuser; George N Thalmann; JP Springer; William H Turner
Antireflux nipples or afferent tubular segments in 70 patients with ileal low pressure bladder substitutes: long-term results of a prospective randomized trial.
The Journal of urology 1996;156(6):1913-7.
1996: SC Ko; Akinobu Gotoh; George N Thalmann; Haiyen E Zhau; D A Johnston; W W Zhang; Chinghai Kao; Leland W K Chung
Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model.
Human gene therapy 1996;7(14):1683-91.
1996: George N Thalmann; R A Sikes; S M Chang; D A Johnston; Andrew C von Eschenbach; Leland W K Chung
Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer.
Journal of the National Cancer Institute 1996;88(12):794-801.
1994: George N Thalmann; P E Anezinis; S M Chang; Haiyen E Zhau; E E Kim; Vicki L Hopwood; Sen Pathak; Andrew C von Eschenbach; Leland W K Chung
Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.
Cancer research 1994;54(10):2577-81.
1993: Urs E Studer; George N Thalmann; E J Zingg
Radical prostatectomy or wait-and-watch?
European urology 1993;24 Suppl 2():24-8.